454 related articles for article (PubMed ID: 12902520)
1. Differentiation of CD8+ T cells from tumor-invaded and tumor-free lymph nodes of melanoma patients: role of common gamma-chain cytokines.
Anichini A; Scarito A; Molla A; Parmiani G; Mortarini R
J Immunol; 2003 Aug; 171(4):2134-41. PubMed ID: 12902520
[TBL] [Abstract][Full Text] [Related]
2. Lack of terminally differentiated tumor-specific CD8+ T cells at tumor site in spite of antitumor immunity to self-antigens in human metastatic melanoma.
Mortarini R; Piris A; Maurichi A; Molla A; Bersani I; Bono A; Bartoli C; Santinami M; Lombardo C; Ravagnani F; Cascinelli N; Parmiani G; Anichini A
Cancer Res; 2003 May; 63(10):2535-45. PubMed ID: 12750277
[TBL] [Abstract][Full Text] [Related]
3. Tumor-reactive CD8+ early effector T cells identified at tumor site in primary and metastatic melanoma.
Anichini A; Molla A; Vegetti C; Bersani I; Zappasodi R; Arienti F; Ravagnani F; Maurichi A; Patuzzo R; Santinami M; Pircher H; Di Nicola M; Mortarini R
Cancer Res; 2010 Nov; 70(21):8378-87. PubMed ID: 20861189
[TBL] [Abstract][Full Text] [Related]
4. Stimulation of cells from a non-invaded and an invaded lymph node with a HER-2+ tumor with peptides corresponding to T-cell epitopes E75 and G89 induced expansion of central memory cells (TCM) from the metastasis-negative lymph nodes.
Ko BK; Efferson CL; Kawano K; Kuerer HM; Sahin A; Murray JL; Ioannides CG
Int J Oncol; 2004 Jun; 24(6):1413-8. PubMed ID: 15138582
[TBL] [Abstract][Full Text] [Related]
5. A shift in the phenotype of melan-A-specific CTL identifies melanoma patients with an active tumor-specific immune response.
Dunbar PR; Smith CL; Chao D; Salio M; Shepherd D; Mirza F; Lipp M; Lanzavecchia A; Sallusto F; Evans A; Russell-Jones R; Harris AL; Cerundolo V
J Immunol; 2000 Dec; 165(11):6644-52. PubMed ID: 11086110
[TBL] [Abstract][Full Text] [Related]
6. Selective responsiveness to common gamma chain cytokines in peripheral blood-derived cytotoxic T lymphocytes induced by Melan-A/MART-1(27-35)targeted active specific immunotherapy.
von Holzen U; Adamina M; Bolli M; Weber WP; Zajac P; Groeper C; Reschner A; Feder C; Schumacher R; Marti W; Oertli D; Heberer M; Spagnoli GC
Int J Cancer; 2005 Jun; 115(2):248-55. PubMed ID: 15688403
[TBL] [Abstract][Full Text] [Related]
7. Frequency and relative fraction of tumor antigen-specific T cells among lymphocytes from melanoma-invaded lymph nodes.
Labarriere N; Pandolfino MC; Raingeard D; Le Guiner S; Diez E; Le Dréan E; Dreno B; Jotereau F
Int J Cancer; 1998 Oct; 78(2):209-15. PubMed ID: 9754654
[TBL] [Abstract][Full Text] [Related]
8. The activatory receptor 2B4 is expressed in vivo by human CD8+ effector alpha beta T cells.
Speiser DE; Colonna M; Ayyoub M; Cella M; Pittet MJ; Batard P; Valmori D; Guillaume P; Liénard D; Cerottini JC; Romero P
J Immunol; 2001 Dec; 167(11):6165-70. PubMed ID: 11714776
[TBL] [Abstract][Full Text] [Related]
9. IL-2 production by virus- and tumor-specific human CD8 T cells is determined by their fine specificity.
Mallard E; Vernel-Pauillac F; Velu T; Lehmann F; Abastado JP; Salcedo M; Bercovici N
J Immunol; 2004 Mar; 172(6):3963-70. PubMed ID: 15004205
[TBL] [Abstract][Full Text] [Related]
10. Skewed maturation of memory HIV-specific CD8 T lymphocytes.
Champagne P; Ogg GS; King AS; Knabenhans C; Ellefsen K; Nobile M; Appay V; Rizzardi GP; Fleury S; Lipp M; Förster R; Rowland-Jones S; Sékaly RP; McMichael AJ; Pantaleo G
Nature; 2001 Mar; 410(6824):106-11. PubMed ID: 11242051
[TBL] [Abstract][Full Text] [Related]
11. Detection and characterization of a novel subset of CD8⁺CD57⁺ T cells in metastatic melanoma with an incompletely differentiated phenotype.
Wu RC; Liu S; Chacon JA; Wu S; Li Y; Sukhumalchandra P; Murray JL; Molldrem JJ; Hwu P; Pircher H; Lizée G; Radvanyi LG
Clin Cancer Res; 2012 May; 18(9):2465-77. PubMed ID: 22307139
[TBL] [Abstract][Full Text] [Related]
12. IL-15-induced human DC efficiently prime melanoma-specific naive CD8+ T cells to differentiate into CTL.
Dubsky P; Saito H; Leogier M; Dantin C; Connolly JE; Banchereau J; Palucka AK
Eur J Immunol; 2007 Jun; 37(6):1678-90. PubMed ID: 17492620
[TBL] [Abstract][Full Text] [Related]
13. Immediate early effector functions of virus-specific CD8+CCR7+ memory cells in humans defined by HLA and CC chemokine ligand 19 tetramers.
Ravkov EV; Myrick CM; Altman JD
J Immunol; 2003 Mar; 170(5):2461-8. PubMed ID: 12594271
[TBL] [Abstract][Full Text] [Related]
14. Three memory subsets of human CD8+ T cells differently expressing three cytolytic effector molecules.
Takata H; Takiguchi M
J Immunol; 2006 Oct; 177(7):4330-40. PubMed ID: 16982867
[TBL] [Abstract][Full Text] [Related]
15. Tetramer-guided analysis of TCR beta-chain usage reveals a large repertoire of melan-A-specific CD8+ T cells in melanoma patients.
Valmori D; Dutoit V; Liénard D; Lejeune F; Speiser D; Rimoldi D; Cerundolo V; Dietrich PY; Cerottini JC; Romero P
J Immunol; 2000 Jul; 165(1):533-8. PubMed ID: 10861093
[TBL] [Abstract][Full Text] [Related]
16. Memory T cells constitute a subset of the human CD8+CD45RA+ pool with distinct phenotypic and migratory characteristics.
Faint JM; Annels NE; Curnow SJ; Shields P; Pilling D; Hislop AD; Wu L; Akbar AN; Buckley CD; Moss PA; Adams DH; Rickinson AB; Salmon M
J Immunol; 2001 Jul; 167(1):212-20. PubMed ID: 11418651
[TBL] [Abstract][Full Text] [Related]
17. Skewed distribution of IL-7 receptor-α-expressing effector memory CD8+ T cells with distinct functional characteristics in oral squamous cell carcinoma.
Lee JJ; Yeh CY; Jung CJ; Chen CW; Du MK; Yu HM; Yang CJ; Lin HY; Sun A; Ko JY; Cheng SJ; Chang YL; Chia JS
PLoS One; 2014; 9(1):e85521. PubMed ID: 24465587
[TBL] [Abstract][Full Text] [Related]
18. Peptide-specific CD8+ T-cell evolution in vivo: response to peptide vaccination with Melan-A/MART-1.
Jäger E; Höhn H; Necker A; Förster R; Karbach J; Freitag K; Neukirch C; Castelli C; Salter RD; Knuth A; Maeurer MJ
Int J Cancer; 2002 Mar; 98(3):376-88. PubMed ID: 11920589
[TBL] [Abstract][Full Text] [Related]
19. Four functionally distinct populations of human effector-memory CD8+ T lymphocytes.
Romero P; Zippelius A; Kurth I; Pittet MJ; Touvrey C; Iancu EM; Corthesy P; Devevre E; Speiser DE; Rufer N
J Immunol; 2007 Apr; 178(7):4112-9. PubMed ID: 17371966
[TBL] [Abstract][Full Text] [Related]
20. Differentiation of human CD8(+) T cells from a memory to memory/effector phenotype.
Tomiyama H; Matsuda T; Takiguchi M
J Immunol; 2002 Jun; 168(11):5538-50. PubMed ID: 12023349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
